Tim Czartoski Named CEO at Genesis Innovation Group

Genesis Innovation Group has appointed Tim Czartoski as CEO, effective April 1. He will serve in an advisory role until that time. 
 
Czartoski is a seasoned, experienced healthcare leader who possesses a deep understanding of the medtech field and brings insightful vision, strong decision-making, and inspirational leadership, resulting in a record of proven success. For 22 years, he was part of DePuy Synthes, the orthopedic company of Johnson & Johnson, with roles progressing from product marketing through strategic innovation and commercial P&L responsibility. Czartoski’s experiences spanned all DePuy Synthes’s businesses, including worldwide president of Joint Reconstruction and leading up to president of DePuy Synthes U.S., with responsibility for all strategic and commercial activities across the comprehensive portfolio of products and services for nearly five years through March 2023. 
 
Czartoski was instrumental in leading DePuy Synthes to progress through changing markets and evolving customer needs while making every effort to create an empowered, inclusive work culture. While at Depuy Synthes, some of the novel innovations he led and partnered to deliver included products and strategies for navigation, robotic assisted surgery, digital healthcare, and total joint replacement systems. Czartoski’s leadership delivered significant value through differentiation, growth, share gains, and strong financial performance.
 
Czartoski earned a bachelor of science degree from The Ohio State University, an MBA from Notre Dame, and a master of science degree from Columbia in technology management. His leadership background, along with his vision and end-to-end knowledge of med-tech from R&D through marketing and commercial execution, in combination with a relentless pursuit of uncovering needs and advancing medical technology solutions, will be a good fit as Genesis aspires to accelerate its innovation model, according to company executives. 

With more than 100 patents and innovations among its founders, Genesis Innovation Group considers itself a leader in medical device development and commercialization. The company partners with medical device companies and surgeon-inventors to develop new technologies that advance human health and medicine. Genesis has founded and/or supported a number of significant technologies broadly recognized in the marketplace, including among others: Shoulder Innovations Inc., HAPPE Spine, Nanochon Inc.,  Sterile Processing Express, Embody (acquired by Zimmer Biomet Holdings Inc.), ProVoyance, Magnesium Development Company, and cultivate(MD).